309 related articles for article (PubMed ID: 37759042)
1. Advances in the pathogenesis and therapeutic strategies of angioimmunoblastic T-cell lymphoma.
Zhang Q; Yin L; Lai Q; Zhao Y; Peng H
Clin Exp Med; 2023 Dec; 23(8):4219-4235. PubMed ID: 37759042
[TBL] [Abstract][Full Text] [Related]
2. Recent Advances in Diagnosis and Therapy of Angioimmunoblastic T Cell Lymphoma.
Mohammed Saleh MF; Kotb A; Abdallah GEM; Muhsen IN; El Fakih R; Aljurf M
Curr Oncol; 2021 Dec; 28(6):5480-5498. PubMed ID: 34940095
[TBL] [Abstract][Full Text] [Related]
3. Evaluation and management of angioimmunoblastic T-cell lymphoma: a review of current approaches and future strategies.
Alizadeh AA; Advani RH
Clin Adv Hematol Oncol; 2008 Dec; 6(12):899-909. PubMed ID: 19209140
[TBL] [Abstract][Full Text] [Related]
4. Angioimmunoblastic T-Cell Lymphoma.
Yabe M; Dogan A; Horwitz SM; Moskowitz AJ
Cancer Treat Res; 2019; 176():99-126. PubMed ID: 30596215
[TBL] [Abstract][Full Text] [Related]
5. [Diagnosis and treatment of angioimmunoblastic T-cell lymphoma and related cancers].
Sakata-Yanagimoto M
Rinsho Ketsueki; 2019; 60(9):1221-1228. PubMed ID: 31597847
[TBL] [Abstract][Full Text] [Related]
6. Effects of stem cell transplantation in patients with peripheral T-cell lymphoma not otherwise specified and angioimmunoblastic T-cell lymphoma.
Yamasaki S; Yoshida S; Kato K; Choi I; Imamura Y; Kohno K; Henzan H; Tanimoto K; Ogawa R; Suehiro Y; Miyamoto T; Eto T; Ohshima K; Akashi K; Iwasaki H;
Int J Hematol; 2020 Jul; 112(1):74-83. PubMed ID: 32297159
[TBL] [Abstract][Full Text] [Related]
7. Angioimmunoblastic T-cell lymphoma with predominant CD8+ tumor-infiltrating T-cells is a distinct immune pattern with an immunosuppressive microenvironment.
Chen Z; Zhu Q; Deng X; Yao W; Zhang W; Liu W; Tang Y; Zhao S
Front Immunol; 2022; 13():987227. PubMed ID: 36325319
[TBL] [Abstract][Full Text] [Related]
8. Angioimmunoblastic T-cell lymphoma: more than a disease of T follicular helper cells.
Lemonnier F; Mak TW
J Pathol; 2017 Aug; 242(4):387-390. PubMed ID: 28543514
[TBL] [Abstract][Full Text] [Related]
9. How I Diagnose Angioimmunoblastic T-Cell Lymphoma.
Xie Y; Jaffe ES
Am J Clin Pathol; 2021 Jun; 156(1):1-14. PubMed ID: 34117736
[TBL] [Abstract][Full Text] [Related]
10. Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma.
Lunning MA; Vose JM
Blood; 2017 Mar; 129(9):1095-1102. PubMed ID: 28115369
[TBL] [Abstract][Full Text] [Related]
11. [Molecular mechanisms of angioimmunoblastic T-cell lymphoma].
Sakata-Yanagimoto M
Rinsho Ketsueki; 2015 Mar; 56(3):246-52. PubMed ID: 25876776
[TBL] [Abstract][Full Text] [Related]
12. IDH2 and TET2 mutations synergize to modulate T Follicular Helper cell functional interaction with the AITL microenvironment.
Leca J; Lemonnier F; Meydan C; Foox J; El Ghamrasni S; Mboumba DL; Duncan GS; Fortin J; Sakamoto T; Tobin C; Hodgson K; Haight J; Smith LK; Elia AJ; Butler D; Berger T; de Leval L; Mason CE; Melnick A; Gaulard P; Mak TW
Cancer Cell; 2023 Feb; 41(2):323-339.e10. PubMed ID: 36736318
[TBL] [Abstract][Full Text] [Related]
13. Follicular Helper T-Cell-derived Nodal Lymphomas: Study of Histomorphologic, Immunophenotypic, Clinical, and RHOA G17V Mutational Profile.
Jain S; Goswami A; Lone MR; Ramteke P; Gogia A; Aggarwal M; Viswanathan GK; Kakkar D; Mandal T; Sharma A; Sahoo R; Baldia A; Sharma MC; Bakhshi S; Pramanik R; Dhawan R; Kumar L; Mallick S
Appl Immunohistochem Mol Morphol; 2023 Mar; 31(3):172-180. PubMed ID: 36806188
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive comparison of international prognostic indexes for follicular helper T-cell lymphoma.
Lee YP; Yoon SE; Cho J; Ko YH; Jo H; Kim SJ; Kim WS
Ann Hematol; 2022 Jul; 101(7):1535-1543. PubMed ID: 35639152
[TBL] [Abstract][Full Text] [Related]
15. [Angioimmunoblastic T-cell lymphoma].
Izutsu K
Nihon Rinsho; 2014 Mar; 72(3):519-23. PubMed ID: 24724413
[TBL] [Abstract][Full Text] [Related]
16. Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project.
Advani RH; Skrypets T; Civallero M; Spinner MA; Manni M; Kim WS; Shustov AR; Horwitz SM; Hitz F; Cabrera ME; Dlouhy I; Vassallo J; Pileri SA; Inghirami G; Montoto S; Vitolo U; Radford J; Vose JM; Federico M
Blood; 2021 Jul; 138(3):213-220. PubMed ID: 34292324
[TBL] [Abstract][Full Text] [Related]
17. The microenvironment in T-cell lymphomas: emerging themes.
Gaulard P; de Leval L
Semin Cancer Biol; 2014 Feb; 24():49-60. PubMed ID: 24316493
[TBL] [Abstract][Full Text] [Related]
18. The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma.
Chihara D; Fanale MA; Miranda RN; Noorani M; Westin JR; Nastoupil LJ; Hagemeister FB; Fayad LE; Romaguera JE; Samaniego F; Turturro F; Lee HJ; Neelapu SS; Rodriguez MA; Wang M; Fowler NH; Davis RE; Medeiros LJ; Hosing C; Nieto YL; Oki Y
Br J Haematol; 2017 Mar; 176(5):750-758. PubMed ID: 27983760
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic focus on angioimmunoblastic T-cell lymphoma: pathogenesis and treatment.
Tari G; Lemonnier F; Morschhauser F
Curr Opin Oncol; 2021 Sep; 33(5):400-405. PubMed ID: 34230442
[TBL] [Abstract][Full Text] [Related]
20. Activating mutations in genes related to TCR signaling in angioimmunoblastic and other follicular helper T-cell-derived lymphomas.
Vallois D; Dobay MP; Morin RD; Lemonnier F; Missiaglia E; Juilland M; Iwaszkiewicz J; Fataccioli V; Bisig B; Roberti A; Grewal J; Bruneau J; Fabiani B; Martin A; Bonnet C; Michielin O; Jais JP; Figeac M; Bernard OA; Delorenzi M; Haioun C; Tournilhac O; Thome M; Gascoyne RD; Gaulard P; de Leval L
Blood; 2016 Sep; 128(11):1490-502. PubMed ID: 27369867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]